Cell Line : CBTCI002-A
Cellosaurus Index : CVCL_UL92
Cellosaurus ID : CBTCI002-A
GDSC1 Name
, GDSC2 Name
: EB-3
Cancer Type : lymphoma
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| CBTCI002-A | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| CBTCI002-A | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| CBTCI002-A | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| CBTCI002-A | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | A-443654 | GDSC1 | 0.0040 | 1.0240 |
|
| CBTCI002-A | A-770041 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| CBTCI002-A | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| CBTCI002-A | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| CBTCI002-A | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| CBTCI002-A | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| CBTCI002-A | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| CBTCI002-A | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | Alisertib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| CBTCI002-A | Alpelisib | GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| CBTCI002-A | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| CBTCI002-A | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| CBTCI002-A | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| CBTCI002-A | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| CBTCI002-A | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CBTCI002-A | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| CBTCI002-A | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD1332 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| CBTCI002-A | AZD2014 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | AZD4547 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| CBTCI002-A | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| CBTCI002-A | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD5438 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| CBTCI002-A | AZD6482 | GDSC1 | 0.0195 | 5.1200 |
|
| CBTCI002-A | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | AZD7762 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CBTCI002-A | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | AZD8055 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| CBTCI002-A | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| CBTCI002-A | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| CBTCI002-A | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| CBTCI002-A | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| CBTCI002-A | BI-2536 | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| CBTCI002-A | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Bleomycin | GDSC1,GDSC2 | 0.0020 | 64.0000 |
|
| CBTCI002-A | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| CBTCI002-A | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| CBTCI002-A | BMS-509744 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | BMS-754807 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Bortezomib | GDSC1,GDSC2 | 0.0000 | 0.0200 |
|
| CBTCI002-A | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| CBTCI002-A | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| CBTCI002-A | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| CBTCI002-A | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| CBTCI002-A | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| CBTCI002-A | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| CBTCI002-A | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| CBTCI002-A | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| CBTCI002-A | CGP-082996 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | CGP-60474 | GDSC1 | 0.0010 | 0.2560 |
|
| CBTCI002-A | CHIR-99021 | GDSC1 | 0.0100 | 10.0000 |
|
| CBTCI002-A | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| CBTCI002-A | CMK | GDSC1 | 0.0156 | 4.0000 |
|
| CBTCI002-A | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| CBTCI002-A | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Crizotinib | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| CBTCI002-A | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Dacarbazine | GDSC2 | 0.0200 | 20.0000 |
|
| CBTCI002-A | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| CBTCI002-A | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| CBTCI002-A | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| CBTCI002-A | Daporinad | GDSC1,GDSC2 | 0.0001 | 1.0000 |
|
| CBTCI002-A | Dasatinib | GDSC1,GDSC2 | 0.0010 | 2.0000 |
|
| CBTCI002-A | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| CBTCI002-A | Docetaxel | GDSC1,GDSC2 | 0.0000 | 3.0000 |
|
| CBTCI002-A | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Doxorubicin | GDSC1 | 0.0040 | 5.0000 |
|
| CBTCI002-A | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| CBTCI002-A | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| CBTCI002-A | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| CBTCI002-A | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| CBTCI002-A | Entinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| CBTCI002-A | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Erlotinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| CBTCI002-A | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| CBTCI002-A | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| CBTCI002-A | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| CBTCI002-A | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| CBTCI002-A | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| CBTCI002-A | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | Gemcitabine | GDSC1,GDSC2 | 0.0001 | 10.0000 |
|
| CBTCI002-A | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| CBTCI002-A | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | GNF-2 | GDSC1 | 0.0050 | 1.2800 |
|
| CBTCI002-A | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| CBTCI002-A | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| CBTCI002-A | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | GSK269962A | GDSC1 | 0.0098 | 5.0000 |
|
| CBTCI002-A | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| CBTCI002-A | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| CBTCI002-A | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| CBTCI002-A | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| CBTCI002-A | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | GW843682X | GDSC1 | 0.0010 | 0.2560 |
|
| CBTCI002-A | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | I-BET-762 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| CBTCI002-A | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Imatinib | GDSC1 | 0.0078 | 2.0000 |
|
| CBTCI002-A | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| CBTCI002-A | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| CBTCI002-A | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Irinotecan | GDSC2 | 0.0050 | 10.0000 |
|
| CBTCI002-A | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| CBTCI002-A | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| CBTCI002-A | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | JW-7-52-1 | GDSC1 | 0.0047 | 1.2000 |
|
| CBTCI002-A | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| CBTCI002-A | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | Lapatinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CBTCI002-A | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| CBTCI002-A | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | LGK974 | GDSC1,GDSC2 | 0.0050 | 10.0000 |
|
| CBTCI002-A | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| CBTCI002-A | Linsitinib | GDSC1,GDSC2 | 0.0025 | 10.0000 |
|
| CBTCI002-A | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | Luminespib | GDSC1,GDSC2 | 0.0003 | 1.0000 |
|
| CBTCI002-A | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| CBTCI002-A | MG-132 | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| CBTCI002-A | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| CBTCI002-A | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| CBTCI002-A | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| CBTCI002-A | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| CBTCI002-A | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CBTCI002-A | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| CBTCI002-A | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Navitoclax | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| CBTCI002-A | Nelarabine | GDSC2 | 0.0200 | 20.0000 |
|
| CBTCI002-A | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | Nilotinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| CBTCI002-A | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CBTCI002-A | Nutlin-3a | GDSC1,GDSC2 | 0.0080 | 10.0000 |
|
| CBTCI002-A | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | NVP-TAE684 | GDSC1 | 0.0078 | 2.0000 |
|
| CBTCI002-A | Obatoclax Mesylate | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| CBTCI002-A | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| CBTCI002-A | OSI-027 | GDSC1,GDSC2 | 0.0040 | 20.0000 |
|
| CBTCI002-A | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Oxaliplatin | GDSC2 | 0.0100 | 20.0000 |
|
| CBTCI002-A | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | PAC-1 | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | Paclitaxel | GDSC1,GDSC2 | 0.0000 | 0.1024 |
|
| CBTCI002-A | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| CBTCI002-A | Palbociclib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| CBTCI002-A | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| CBTCI002-A | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| CBTCI002-A | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| CBTCI002-A | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| CBTCI002-A | Parthenolide | GDSC1 | 0.0195 | 5.0000 |
|
| CBTCI002-A | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| CBTCI002-A | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | PD0325901 | GDSC1,GDSC2 | 0.0003 | 2.5000 |
|
| CBTCI002-A | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| CBTCI002-A | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| CBTCI002-A | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| CBTCI002-A | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | PHA-665752 | GDSC1 | 0.0078 | 2.0000 |
|
| CBTCI002-A | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| CBTCI002-A | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Pictilisib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| CBTCI002-A | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Piperlongumine | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| CBTCI002-A | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| CBTCI002-A | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| CBTCI002-A | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| CBTCI002-A | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Rapamycin | GDSC1,GDSC2 | 0.0000 | 0.1000 |
|
| CBTCI002-A | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| CBTCI002-A | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| CBTCI002-A | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | S-Trityl-L-cysteine | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| CBTCI002-A | Saracatinib | GDSC1 | 0.0078 | 2.0000 |
|
| CBTCI002-A | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| CBTCI002-A | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| CBTCI002-A | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | SN-38 | GDSC1,GDSC2 | 0.0000 | 0.1000 |
|
| CBTCI002-A | SNX-2112 | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | Sorafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| CBTCI002-A | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | Sunitinib | GDSC1 | 0.0312 | 8.0000 |
|
| CBTCI002-A | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| CBTCI002-A | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| CBTCI002-A | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| CBTCI002-A | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| CBTCI002-A | Teniposide | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | TGX221 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| CBTCI002-A | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| CBTCI002-A | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| CBTCI002-A | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| CBTCI002-A | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | Topotecan | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Tozasertib | GDSC1 | 0.0078 | 2.0000 |
|
| CBTCI002-A | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | Tretinoin | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| CBTCI002-A | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | TW 37 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| CBTCI002-A | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| CBTCI002-A | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | UNC0638 | GDSC1,GDSC2 | 0.0050 | 40.0000 |
|
| CBTCI002-A | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| CBTCI002-A | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| CBTCI002-A | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| CBTCI002-A | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| CBTCI002-A | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| CBTCI002-A | Vincristine | GDSC2 | 0.0030 | 3.0000 |
|
| CBTCI002-A | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| CBTCI002-A | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| CBTCI002-A | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| CBTCI002-A | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| CBTCI002-A | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CBTCI002-A | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | WH-4-023 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | WZ-1-84 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| CBTCI002-A | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | XAV939 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| CBTCI002-A | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| CBTCI002-A | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | YK-4-279 | GDSC1,GDSC2 | 0.0200 | 20.0000 |
|
| CBTCI002-A | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| CBTCI002-A | Z-LLNle-CHO | GDSC1 | 0.0100 | 2.5600 |
|
| CBTCI002-A | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| CBTCI002-A | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| CBTCI002-A | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CBTCI002-A | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| CBTCI002-A | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC